1-9 of 9
Farrukh T Awan
Close
Sort by
Journal Articles

CD19-directed CART Therapy for T cell/Histiocyte Rich Large B-cell Lymphoma

Priyanka A Pophali, Joshua A Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T Awan, Shatha Farhan, Natalie S. Grover, Talal Hilal, Madiha Iqbal, Joeseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto Schachter, Craig S Sauter, Mehdi Hamadani, Alex F. Herrera, Roni Shouval, Mazyar Shadman
Journal: Blood Advances
Blood Adv bloodadvances.2024013863.
https://doi.org/10.1182/bloodadvances.2024013863
Published: 2024
Includes: Supplemental data
Journal Articles

CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

Clinical Trials & Observations
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T. Awan, Alexandra E. Rojek, Peter A. Riedell, Madiha Iqbal, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Sawa Ito, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3528–3531.
https://doi.org/10.1182/bloodadvances.2023012255
Published: 2024
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL

Farrukh T. Awan, Daniel Addison, Feras Alfraih, Sergio J. Baratta, Rodrigo Noronha Campos, María Silvana Cugliari, Yeow Tee Goh, Valery Alexandrovich Ionin, Stefanie Mundnich, Aaron L. Sverdlov, Constantine Tam, Loïc Ysebaert
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5516–5525.
https://doi.org/10.1182/bloodadvances.2022007938
Published: 2022
Includes: Supplemental data
Journal Articles

Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists

Clinical Trials & Observations
Kristin L. Koenig, Ying Huang, Emily K. Dotson, Shane Sheredy, Seema A. Bhat, John C. Byrd, Emily Desmond, Jill Ford, Shauna Iarocci, Jeffrey A. Jones, Margaret S. Lucas, Mollie E. Moran, Tracy E. Wiczer, Jennifer A. Woyach, Farrukh T. Awan, Kerry A. Rogers
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4860–4863.
https://doi.org/10.1182/bloodadvances.2020002593
Published: 2020
Includes: Supplemental data
Journal Articles

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

Clinical Trials & Observations
Farrukh T. Awan, Anna Schuh, Jennifer R. Brown, Richard R. Furman, John M. Pagel, Peter Hillmen, Deborah M. Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn, Melanie M. Frigault, Ahmed Hamdy, Raquel Izumi, Bolan Linghu, Priti Patel, Min Hui Wang, John C. Byrd
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1553–1562.
https://doi.org/10.1182/bloodadvances.2018030007
Published: 2019
Journal Articles

Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib

Emily M. McWilliams, Christopher R. Lucas, Timothy Chen, Bonnie K. Harrington, Ronni Wasmuth, Amanda Campbell, Kerry A. Rogers, Carolyn M. Cheney, Xiaokui Mo, Leslie A. Andritsos, Farrukh T. Awan, Jennifer Woyach, William E. Carson, III, Jonathan Butchar, Susheela Tridandapani, Erin Hertlein, Carlos E. Castro, Natarajan Muthusamy, John C. Byrd
Journal: Blood Advances
Blood Adv (2019) 3 (3): 447–460.
https://doi.org/10.1182/bloodadvances.2018025684
Published: 2019
Includes: Supplemental data
Journal Articles

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Clinical Trials & Observations
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1739–1748.
https://doi.org/10.1182/bloodadvances.2017009720
Published: 2017
Includes: Supplemental data
Journal Articles

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

Clinical Trials & Observations
Cecelia R. Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, Heather Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber L. Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha M. Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin K. Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1584–1588.
https://doi.org/10.1182/bloodadvances.2017007302
Published: 2017
Includes: Supplemental data